Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.050 GeneticVariation disease BEFREE This case-control study assessed the association between H19 genetic variants and susceptibility to bladder cancer in a Chinese Han population. 29595036 2019
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.050 Biomarker disease BEFREE The human IGF2-P4 and H19 promoters are highly active in a variety of human cancers (including bladder cancer), while existing at a nearly undetectable level in the surrounding normal tissue.Single promoter vectors expressing diphtheria toxin A-fragment (DTA) under the control regulation of IGF2-P4 or H19 regulatory sequences (IGF2-P4-DTA and H19-DTA) were previously successfully used in cell lines, animal models and recently in human patients with superficial cell carcinoma of the bladder (treated with H19-DTA). 21162716 2010
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.050 GeneticVariation disease LHGDN In this study we examined whether sequence variants within the H19 gene are associated with the risk of developing bladder cancer. 18262338 2008
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.050 GeneticVariation disease BEFREE In this study we examined whether sequence variants within the H19 gene are associated with the risk of developing bladder cancer. 18262338 2008
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.050 Biomarker disease LHGDN Examination of IGF2 and H19 loss of imprinting in bladder cancer. 18006818 2007
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.050 PosttranslationalModification disease BEFREE Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. 11726548 2001